Genetic treasure hunt: 3600 patients help decode disease genes
NCT ID NCT02266615
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is building a biobank of genetic samples and medical information from 3600 patients visiting the Clinical Genetics department in Maastricht. Researchers will use the stored data to compare genes and discover unknown functions. The goal is to better understand how genetic changes cause disease, which could guide future diagnostics and treatments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this biobank could help scientists discover new links between genes and diseases, leading to better diagnosis or treatments in the future.
- What could go wrong
- This is an observational biobank study, not a treatment trial. It collects data for future research, so direct benefits to participants are unlikely and results may take years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,600 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Sep 2014
- Expected to finish
-
Jan 2035
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital and who get blood or tissue sampled for DNA diagnostics.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital * Withdrawal of body material for genetic diagnostics. Exclusion Criteria: * Patient does not understand the Dutch language.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Genetic disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Maastricht University Medical Center
RECRUITINGMaastricht, Limburg, 6229 HV, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood draw map a Baby's genetic risks?
- A gene variant found mostly on one island could reshape breast cancer screening
- Hidden gut inflammation may drive familial mediterranean fever
- Rare disease diagnoses could get faster as ontario tests wider access to genomic sequencing
- Inherited genes may hold key to lung cancer risk
- Reading every gene: a new quest to end the diagnostic odyssey for sick children